These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15997637)

  • 21. Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy.
    Brisinda G; Cadeddu F; Brandara F; Marniga G; Vanella S; Nigro C; Maria G
    Br J Surg; 2008 Jun; 95(6):774-8. PubMed ID: 18425796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
    Wang J; Lin S; Zhang X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botox produces functional weakness in non-injected muscles adjacent to the target muscle.
    Yaraskavitch M; Leonard T; Herzog W
    J Biomech; 2008; 41(4):897-902. PubMed ID: 18184613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral versus posterior injection of botulinum toxin in the internal anal sphincter for the treatment of acute anal fissure.
    Othman I
    S Afr J Surg; 2010 Feb; 48(1):20-2. PubMed ID: 20496820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin. Development for therapeutic purposes].
    Ceballos-Baumann A
    Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose standardization of botulinum toxin.
    Van den Bergh PY; Lison DF
    Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.